Biotech

All Articles

Editas cashes in on Vertex Cas9 licensing rights for $57M

.Against the backdrop of a Cas9 license war that declines to pass away, Editas Medicine is actually ...

Ultragenyx modifies genetics therapy dosing to call up efficacy

.A minority of patients taking Ultragenyx Pharmaceutical's Wilson ailment genetics therapy UX701 hav...

Biopharma discharge price supports in Q3: Brutal Biotech analysis

.As summertime heat energy relies on cool winds, wishes that this year would bring common industry c...

J &amp J goes down period 2 dengue applicant in most recent change coming from vaccinations

.Johnson &amp Johnson's deprioritization of its contagious health condition pipeline has professed a...

Relay loses 10% of workers after earlier cutbacks in July

.Preciseness medication biotech Relay Therapeutics is losing about 10% of its own labor force in att...

Pentixapharm scores $22M IPO to deposit radiopharma trials

.Pentixapharm has generated nearly 20 thousand euros ($ 22 thousand) from an IPO, along with the Ger...

Lundbeck faucets Charles Waterway for AI-enabled neuro drug invention

.Lundbeck has actually utilized Charles Waterway Laboratories' artificial intelligence capabilities ...

Big pharma, biotech 'won't automatically be symbiotic' in AI: S&ampP

.Big Pharma is investing highly in AI to reduce growth timelines and foster development. However ins...

I &amp I biotech Triveni raises $115M for preclinical antibodies

.Triveni Biography has actually roped in $115 million in set B funds to accelerate preclinical antib...

IGM pivots from cancer to autoimmune, shaking up C-suite

.IGM Biosciences finished in 2013 laying off personnel and also improving its own cancer pipe. Now, ...